Evaluation of Vitamin D and Some Liver Enzymes in Iraqi Colorectal Cancer Patients and those Without Colorectal Cancer

Authors

  • zainab Middle Technical University, College of Health and Medical Techniques, Department of Medical Laboratory Techniques, Baghdad, Iraq
  • Ahmed GH. Sabbar Department of Medical Laboratory Techniques, College of Health and Medical Techniques, Middle Technical University, Baghdad, Iraq
  • Wajeeh K. Obaid Department of Community Health Medical Technical Institute, Middle Technical University, Baghdad, Iraq

DOI:

https://doi.org/10.32792/utq/utjsci/v13i1.1443

Keywords:

biomarkers, CLIA, colorectal cancer, liver enzyme, vitamin D

Abstract

Abstract—Colorectal cancer (CRC) is a major global health concern, described as the uncontrolled growing of cells in the colon or rectum. Vitamin D, metabolized in the liver and has garnered attention for its potential protective effects against CRC. The aim of this research is to evaluate vitamin D levels and its link with some liver enzymes in Iraqi participants with colorectal cancer. Overall, 70 colorectal cancer cases-divided into 35 newly diagnosed and 35 under medication were included, along with 30 individuals without colorectal cancer as controls. Blood sample were collected from Iraqi CRC patients and controls. Serum levels of vitamin D and liver biomarkers were analyzed using Cobas C311 and Chemiluminescence Immunoassay technology. The result showed significant variances in vitamin D levels between the studied groups (p=0.0001), with an inverse relationship between vitamin D and alkaline phosphatase (r=-0.33, p=0.0007). This study suggests that vitamin D could have a potential regulatory role in colorectal cancer patients.

References

‎[1]‎ R. L. Siegel, A. N. Giaquinto, and A. Jemal, ‎‎"Cancer statistics, 2024," CA: a cancer journal ‎for [1]‎ A. N. M. Ali and S. N. Muslim, "Breast ‎Cancer in Iraq: A Comprehensive Review of ‎Disease Burden, Risk Factors, and Healthcare ‎Response," South Asian Res J Bio Appl Biosci, ‎vol. 7, pp. 349-360, 2025.‎

clinicians, vol. 74, pp. 12-49, 2024.‎

‎[2]‎ A. N. M. Ali and S. N. Muslim, "Breast Cancer in ‎Iraq: A Comprehensive Review of Disease ‎Burden, Risk Factors, and Healthcare Response," ‎South Asian Res J Bio Appl Biosci, vol. 7, pp. ‎‎349-360, 2025.‎

‎ [3]‎ N. A. Alwan, F. Lami, M. Al Nsoor, and D. Kerr, ‎‎"Trends in the Incidence and Mortality of the ‎Most Common Cancers in Iraq (Iraqi Cancer ‎Registry 1999-2019)," The Gulf Journal of ‎Oncology, vol. 1, pp. 47-57, 2022.‎

‎[4]‎ S. Ibrahem, H. Ahmed, and S. Zangana, "Trends ‎in colorectal cancer in Iraq over two decades: ‎incidence, mortality, topography and ‎morphology," Annals of Saudi Medicine, vol. 42, ‎pp. 252-261, 2022.‎

‎[5]‎ B. F. Mohammad and I. I. Andsoy, "Health ‎behaviors, knowledge, screening, and attitudes ‎toward colorectal cancer among Iraqi adults," ‎Public Health Nursing, vol. 41, pp. 514-524, ‎‎2024.‎

‎[6]‎ S. Christakos, P. Dhawan, A. Porta, L. J. Mady, ‎and T. Seth, "Vitamin D and intestinal calcium ‎absorption," Molecular and cellular ‎endocrinology, vol. 347, pp. 25-29, 2011.‎

‎[7]‎ H. F. DeLuca, "Overview of general physiologic ‎features and functions of vitamin D," The ‎American journal of clinical nutrition, vol. 80, ‎pp. 1689S-1696S, 2004.‎

‎[8]‎ S. Van Cromphaut, K. Rummens, I. Stockmans, ‎E. Van Herck, F. Dijcks, A. Ederveen, et al., ‎‎"Intestinal calcium transporter genes are ‎upregulated by estrogens and the reproductive ‎cycle through vitamin D receptor‐independent ‎mechanisms," Journal of Bone and Mineral ‎Research, vol. 18, pp. 1725-1736, 2003.‎

‎[9]‎ S. Y. Na, K. B. Kim, Y. J. Lim, and H. J. Song, ‎‎"Vitamin D and Colorectal Cancer: Current ‎Perspectives and Future Directions," J Cancer ‎Prev, vol. 27, pp. 147-156, Sep 30 2022.‎

‎[10]‎ E. Yassıbaş, H. İ. Önen, M. Kerem, O. Toka, and ‎G. Samur, "Vitamin D Receptor Gene ‎Polymorphism and Serum Vitamin D Levels with ‎the Risk of Colorectal Cancer: An Observational ‎Case-Control Study," p. 16, 2022.‎

‎[11]‎ Q.-E. Ling, S.-Q. Ni, Y. Jiao, and L.-X. Liu, ‎‎"Unlocking the sun’s potential: Vitamin D’s role ‎in battling colorectal cancer," Journal of ‎Nutritional Oncology, vol. 9, pp. 1-9, 2024.‎

‎[12]‎ A. Ottaiano, S. Facchini, M. Santorsola, G. Nasti, ‎G. Facchini, L. Montella, et al., "Circulating ‎vitamin D level and its impact on mortality and ‎recurrence in stage III colorectal cancer patients: ‎a systematic review and meta-analysis," ‎Cancers, vol. 15, p. 3012, 2023.‎

‎[13]‎ L. Wang, R. Xu, M. Wang, M. Wang, S. Su, Y. ‎Nian, et al., "Exploration and Identification of ‎Vitamin D and Related Genes as Potential ‎Biomarkers for Colorectal Tumors," ‎OncoTargets and Therapy, vol. 18, pp. 129-145, ‎‎2025.‎

‎[14]‎ G. Wagener, Liver anesthesiology and critical ‎care medicine: Springer Cham, 2018.‎

‎[15]‎ M. m. He, Z. Fang, D. Hang, F. Wang, G. ‎Polychronidis, L. Wang, et al., "Circulating liver ‎function markers and colorectal cancer risk: A ‎prospective cohort study in the UK Biobank," ‎International journal of cancer, vol. 148, pp. ‎‎1867-1878, 2021.‎

‎[16]‎ J. T. Keane, H. Elangovan, R. A. Stokes, and J. E. ‎Gunton, "Vitamin D and the liver—correlation ‎or cause?," Nutrients, vol. 10, p. 496, 2018.‎

‎[17]‎ D. George and P. Mallery, IBM SPSS statistics 29 ‎step by step: A simple guide and reference: ‎Routledge. New York, 2019.‎

‎[18]‎ A. K. Fenercioglu, "The Anti-Inflammatory ‎Roles of Vitamin D for Improving Human ‎Health," Current Issues in Molecular Biology, ‎vol. 46, pp. 13514-13525, 2024.‎

‎[19]‎ X. Zhang, Y. He, X. Li, R. Shraim, W. Xu, L. ‎Wang, et al., "Circulating 25-hydroxyvitamin D ‎and survival outcomes of colorectal cancer: ‎evidence from population-based prospective ‎cohorts and Mendelian randomisation," British ‎journal of cancer, vol. 130, pp. 1585-1591, ‎‎2024.‎

‎[20]‎ G. Ferrer-Mayorga, A. Muñoz, and J. M. ‎González-Sancho, "Vitamin D and colorectal ‎cancer," in Feldman and Pike's Vitamin D, ed: ‎Elsevier, 2024, pp. 859-899.‎

‎[21]‎ D. Lowe and S. John, Alkaline Phosphatase: ‎StatPearls Publishing LLC, 2019.‎

‎[22]‎ T. Gür, H. Demir, and M. Ç. Kotan, "Tumor ‎markers and biochemical parameters in colon ‎cancer patients before and after chemotherapy," ‎Asian Pacific Journal of Cancer Prevention, vol. ‎‎12, pp. 3147-50, 2011.‎

‎[23]‎ M. W. Saif, D. Alexander, and C. M. Wicox, ‎‎"Serum alkaline phosphatase level as a ‎prognostic tool in colorectal cancer: a study of ‎‎105 patients," The journal of applied research, ‎vol. 5, pp. 88-95, 2005.‎

‎[24]‎ O. Ojo, M. Asaolu, O. A. Akinlua, and A. Atiba, ‎‎"Serum marker enzymes activities in cancer ‎patients," Journal of Chemistry and ‎Biochemistry, vol. 4, pp. 15-21, 2016.‎

‎[25]‎ M. J. Hasan, M. M. Bakheet, H. H. Ali, M. K. A. ‎Al-Saedi, and M. Q. Mohammed, "Dual Role of ‎miR-150 in Colorectal Cancer Progression: A ‎Quantitative Real-Time PCR Study," Al-Rafidain ‎Journal of Medical Sciences, vol. 8, pp. 221-‎‎229, 2025.‎

‎[26]‎ H. A. Rajab, "The effect of vitamin D level on ‎parathyroid hormone and alkaline phosphatase," ‎Diagnostics, vol. 12, p. 2828, 2022.‎

‎[27]‎ T. Ao, J. Kikuta, and M. Ishii, "The effects of ‎vitamin D on immune system and inflammatory ‎diseases," Biomolecules, vol. 11, p. 1624, 2021.‎

‎[28]‎ C.-Y. Yang, P. S. Leung, I. E. Adamopoulos, and ‎M. E. Gershwin, "The implication of vitamin D ‎and autoimmunity: a comprehensive review," ‎Clinical reviews in allergy & immunology, vol. ‎‎45, pp. 217-226, 2013.‎

‎[29]‎ M. H. El Gayar, K. M. Makboul, L. M. Hindawy, ‎and A. M. Saleh, "Study of the relationship ‎between colorectal cancer and vit D ‎defficiency," Egyptian Journal of Obesity, ‎Diabetes and Endocrinology, vol. 2, pp. 61-66, ‎‎2016.‎

Downloads

Published

2026-06-01

Issue

Section

Articles

Categories

How to Cite

zainab, Ahmed GH. Sabbar, & Wajeeh K. Obaid. (2026). Evaluation of Vitamin D and Some Liver Enzymes in Iraqi Colorectal Cancer Patients and those Without Colorectal Cancer. University of Thi-Qar Journal of Science, 13(1), 9-13. https://doi.org/10.32792/utq/utjsci/v13i1.1443